Healthcare • Biotechnology
EODHD (TTM) · as of Oct 14, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if ACOG is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
6 top institutions tracked
Last 13F trend: distributing (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: bullish
Last trade: buy 13 days ago
Red flags: 2
26 filers reported a long position in ACOG for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Opaleye Management Inc. | $20.9M | 2.9M | +13% |
| Solas Capital Management, LLC | $13.9M | 1.9M | Unchanged |
| AWM Investment Company, Inc. | $12.1M | 1.7M | Unchanged |
| Cable Car Capital, LP | $10M | 1.4M | Unchanged |
| Ikarian Capital, LLC | $6M | 836.3K | -20.8% |
| SPHERA FUNDS MANAGEMENT LTD. | $3.9M | 545.8K | -3.8% |
| Alyeska Investment Group, L.P. | $2.6M | 365K | Unchanged |
| Aristides Capital LLC | $1.6M | 218.5K | Unchanged |
| BOOTHBAY FUND MANAGEMENT, LLC | $1.4M | 189.1K | -26.2% |
| CANTOR FITZGERALD, L. P. | $786.4K | 108.9K | -42.3% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.